- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Do | Pfizer and BioNTech start trialing booster shot for COVID-19 vaccine | ||
| Do | Moderna announces capital investments to boost COVID-19 vaccine production | ||
| Do | FDA says J&J COVID-19 vaccine is effective and safe | ||
| Do | Coming of Phage: Clinical trial underscores safety of technology battling E. coli triggered UTIs | ||
| Do | German program using whole genome sequencing to diagnose rare diseases and cancer risk | ||
| Di | Findings of new study may help inform the design of next-generation COVID-19 vaccines, as new variants emerge | ||
| Di | China's Clover generates US$230m in funding as its COVID-19 vaccine candidate edges towards late stage clinical trial | ||
| Di | Developing vaccines and therapeutics for virus variants: FDA releases new guidance | ||
| Di | Sanofi and GSK target Q4 2021 for COVID-19 vaccine rollout | ||
| Di | Sanofi to help manufacture Janssen COVID-19 vaccine | ||
| Di | 'Vaccines are working': UK unveils real-world data from vaccination campaign | ||
| 22.02. | Setback for AstraZeneca checkpoint inhibitor in US bladder cancer treatment | ||
| 22.02. | Pfizer/BioNTech COVID-19 vaccine can be stored at standard freezer temperature for 2 weeks, say companies | ||
| 22.02. | Celltrion secures EU approval for its adalimumab biosimilar | ||
| 22.02. | UK to launch new US$1.1bn DARPA-like research agency to support high risk, high reward science | ||
| 22.02. | Pfizer/BioNTech to trial COVID-19 vaccine in pregnant women and children | ||
| 18.02. | Quotient acquisition of Arcinova aimed at 'streamlining' early development process for biotech and pharma companies | ||
| 18.02. | Charles River acquires Cognate BioServices to expand cell and gene therapy programs | ||
| 18.02. | Avacta: Rapid COVID-19 antigen test shows 'very good sensitivity' and generates 'no false positive' results | ||
| 18.02. | Europe sets out plan to tackle coronavirus variants | ||
| 18.02. | South Africa starts administering Janssen COVID-19 vaccine to health workers | ||
| 16.02. | WHO authorizes AstraZeneca COVID-19 vaccine for emergency use | ||
| 16.02. | Preventing cellular hijacking: Study pinpoints potential pathway to new therapeutic approaches for COVID-19 | ||
| 16.02. | Sensorion and Institut Pasteur announce new gene therapy collaboration for hearing loss | ||
| 16.02. | Bristol Myers Squibb to leverage Molecular Template platform against multiple cancer targets |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
